Cancers Associated With Mesothelin Expression clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Study of HPN536 in Patients With Advanced Cancers Associated With Mesothelin Expression
Sorry, in progress, not accepting new patients
An open-label, Phase 1/2a study of HPN536 as monotherapy to assess the safety, tolerability and PK in patients with advanced cancers associated with mesothelin expression.
at UCLA
Last updated: